14.2 CT Colonography & Colorectal Imaging
Key Takeaways
- CT colonography (virtual colonoscopy) screens average-risk adults starting at 45, evaluates patients with incomplete optical colonoscopy, and uses fecal tagging in reduced-prep protocols to distinguish stool from true polyps.
- CO2 insufflation has replaced room air at most sites because it is resorbed faster, reducing post-procedure bloating; inadequate colonic distention is the leading cause of a nondiagnostic exam.
- Both supine and prone (or decubitus) acquisitions are required — a fixed polyp stays put between positions while mobile stool shifts, which is the core diagnostic logic of the exam.
- C-RADS grades colonic findings C1 (no polyp ≥6mm) through C4 (mass ≥30mm/obstructing), with C2 (6-9mm) as the intermediate surveillance-vs-colonoscopy category and a parallel E1-E4 scale for extracolonic findings.
- Standard screening CTC uses low-dose, non-IV-contrast technique with primary 2D reading and 3D fly-through reserved for problem-solving — not routine primary interpretation, and is a fundamentally different study from a full-dose IV-contrast colorectal cancer staging CT.
Why CT Colonography Is a High-Yield Topic
CT colonography (CTC), also called virtual colonoscopy, is explicitly called out in the ARRT content specifications' "Additional Procedures" focus theme and appears throughout the Procedures domain's abdomen/pelvis case items. It is high-yield for three reasons: it is a screening exam performed on healthy patients (so technique errors have outsized consequences), its protocol is genuinely unlike any other abdominal CT (air/CO2 as the "contrast" agent, dual positioning, low dose), and it has its own structured reporting system (C-RADS) that the exam likes to test directly.
Indications and Patient Preparation
CTC is used for average-risk colorectal cancer screening (average-risk adults, generally starting at age 45 per current U.S. Preventive Services Task Force guidance), for patients with an incomplete optical colonoscopy (obstructing lesion, tortuous colon, failed cecal intubation), and for patients who cannot tolerate or are not candidates for sedation/anesthesia.
Two bowel-preparation approaches exist:
- Full cathartic prep: similar laxative regimen to optical colonoscopy, clearing the colon of stool so polyps are unobscured.
- Reduced-prep ("prepless") technique: uses fecal tagging — oral iodinated or barium contrast taken with meals before the exam — to opacify residual stool and fluid electronically, so software (or the reader) can distinguish tagged stool from a true soft-tissue polyp. This improves patient acceptance without sacrificing accuracy when done correctly.
Some protocols add an IM or IV spasmolytic agent (glucagon or hyoscine butylbromide) just before scanning to relax colonic peristalsis and reduce spasm-related false narrowing, though this is not universal.
Contraindications matter on the exam too: acute diverticulitis, suspected bowel perforation, toxic megacolon, and recent colonic biopsy/polypectomy are reasons to defer or cancel insufflation — forcing gas into an already-compromised colon risks perforation. A question describing fever, peritoneal signs, and a recent colonoscopy with biopsy is testing whether you recognize CTC should be postponed, not rushed to "confirm" the diagnosis.
The Acquisition: Insufflation and Dual Positioning
The defining technical steps of CTC:
- Colonic insufflation. The colon must be distended for any lesion to be visible; a collapsed segment can hide or fake a mass. Automated CO2 insufflators have replaced manual room-air insufflation at most sites because CO2 is resorbed by the bowel mucosa far faster than room air, meaning less post-procedure bloating and cramping for the patient — this is a frequently tested contrast between the two gases.
- Two patient positions — supine AND prone (or a decubitus position if prone is not tolerated). This is the single most-tested technique fact in CTC. Repositioning causes mobile residual stool and fluid to shift to a new dependent location, while a true, fixed polyp stays attached to the same point on the bowel wall in both acquisitions. A finding that "moves" between the two series is stool, not a polyp — inadequate distention or a single-position acquisition is the most common cause of a nondiagnostic exam.
- Low-dose technique. Because the "contrast" is gas, not iodine, and the target pathology (a polyp) has high inherent contrast against air, low mAs settings are used for both positions — a deliberate dose-reduction strategy that still preserves diagnostic conspicuity, unlike routine abdominal CT.
IV contrast is not part of a standard screening CTC; it may be added for symptomatic or staging indications, but that converts the study into a different (non-screening) protocol.
Accuracy and CTC's Role vs. Colorectal Staging CT
Per-patient sensitivity for CTC detecting polyps ≥10 mm approaches 90%, comparable to optical colonoscopy for clinically significant lesions, though sensitivity drops for smaller (6-9 mm) polyps — one reason C2 findings get a surveillance option rather than an automatic colonoscopy referral. It is important not to confuse screening CTC with colorectal cancer staging CT: once a colorectal malignancy is already diagnosed (typically by optical colonoscopy with biopsy), a separate, standard IV-contrast-enhanced chest/abdomen/pelvis CT is ordered for staging — looking for nodal disease and distant metastases (liver, lung, peritoneum). CT is a poor tool for local T-staging (depth of bowel-wall invasion), which is better assessed with rectal MRI or endorectal ultrasound, particularly for rectal cancer surgical planning. The exam expects you to keep these two very different pelvic/colon CT applications — a low-dose air-distended screening study versus a full-dose IV-contrast staging study — clearly separated.
C-RADS: The Reporting System
CT Colonography Reporting and Data System (C-RADS), most recently updated in 2023, standardizes both colonic and extracolonic findings using two parallel scales:
| Colonic (C) category | Finding | Recommended action |
|---|---|---|
| C1 | No polyp ≥6 mm | Routine screening interval (typically 5 years) |
| C2 | One or two polyps 6-9 mm (C2a) or a benign-appearing mass-like diverticular stricture (C2b, added 2023) | Short-interval CTC surveillance or optical colonoscopy |
| C3 | A polyp ≥10 mm, or a mass <30 mm | Optical colonoscopy referral |
| C4 | Colonic mass ≥30 mm or an obstructing lesion suspicious for malignancy | Optical colonoscopy / surgical referral |
A parallel E (extracolonic) category, E1-E4, grades incidental findings outside the colon by clinical significance, from E1 (normal) to E4 (a finding requiring urgent action, such as an aortic aneurysm).
Reading Strategy and a Common Trap
Modern CTC interpretation uses primary 2D review with 3D endoluminal ("fly-through") review reserved for problem-solving equivocal findings — the reverse of how many technologists assume it works. Electronic cleansing software subtracts tagged fluid/stool from the reconstructed images, but a poorly tagged or poorly distended segment defeats this software regardless of reconstruction quality.
Exam trap: a question describing a nondiagnostic CTC due to a collapsed rectosigmoid segment is testing whether you recognize inadequate distention/positioning, not scanner hardware, as the cause — the fix is repeat insufflation and repositioning, not a different reconstruction kernel.
During CT colonography, why are both supine and prone (or decubitus) acquisitions required?
A CT colonography study identifies a single 7 mm polyp with no other findings. What is the correct C-RADS category and typical recommendation?
A patient with known colorectal cancer needs to be evaluated for nodal and distant metastatic spread. Which study is appropriate, and how does it differ from a screening CT colonography?